Grifols shares tumble after Brookfield drops takeover plan
Canadian fund Brookfield said on Wednesday it has dropped its plan to take over Spain's Grifols due to a disagreement over ...
Nestle upgraded to Equal Weight from Underweight at Morgan Stanley
Morgan Stanley analyst Sarah Simon upgraded Nestle (NSRGY) to Equal Weight from Underweight with a price target of $85, down from $92. The firm ...
More turnover at the top, but this bull still believes in the Weight Watchers parent
In the case of WW, analyst Linda Bolton Weiser assigned the stock a buy rating back in March, in a note framed around the question, "Why would an investor be interested in investing in WW, which ...
Amgen’s stock closes off lows to avoid worst day in 24 years as weight-loss-drug data underwhelms
Amgen Inc.’s stock closed down 4.8% Tuesday, after the company said a mid-stage trial of its weight-loss treatment MariTide showed up to 20% average weight loss at 52 weeks. Analysts were expecting ...
Weight-loss-drug makers’ stocks get a boost from new Biden coverage proposal, but will it hold up?
The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were higher across the board ...
Game Rant14h
CoD Warzone: Best RAAL MG Loadout
This LMG is rising in popularity. Find the best Warzone RAAL MG loadout along with the best attachments to use in this guide ...
Amgen Obesity Drug Cut Weight in Closely Watched Study
Study subjects taking the company’s MariTide lost about 20% of their weight in the 52-week trial.